|
Dec. 01, 2020 |
|
|
Jan. 21, 2026 |
|
|
jRCTs061200032 |
The feasibility analyses of intranasal dexmedetomidine for premedication in pediatric patients |
|
Intranasal dexmedetomidine for premedication |
Higuchi Hitoshi |
||
Okayama Unisersity Hospital |
||
2-5-1 Shikara-cho, Kita-ku, Okayama |
||
+81-86-235-6721 |
||
higuti@md.okayama-u.ac.jp |
||
Higuchi Hitoshi |
||
Okayama Univesity Hospital |
||
2-5-1 Shikara-cho, Kita-ku, Okayama |
||
+81-86-235-6721 |
||
higuti@md.okayama-u.ac.jp |
Not Recruiting |
Dec. 01, 2020 |
||
| Jan. 15, 2021 | ||
| 60 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
1. Pediatric patients under 15 years who are scheduled to undergo dental treatments under general anesthesia at the Center of the Special Needs Dentistry of Okayama University Hospital. |
||
1. Pediatric patients who have a medical history of anaphylaxis against midazolam and/or dexmedetomidine. |
||
| No limit | ||
| 15age old not | ||
Both |
||
Dental Caries |
||
1. Oral administration of midazolam for premedication |
||
Developmental disoirders, Intellectual disability, Autism |
||
Midazolam, dexmedetomidine, premedication |
||
D003731 |
||
D008874, D000284, D020927, D00028, D011292 |
||
The numbers and rates of patients who accepted oral midazolam, rejected oral midazolam but accepted nasal dexmedetomidine, rejected both of oral midazolam and nasal dexmedetomidine. |
||
1. Sedation Score at anesthesia induction. |
||
| Okayama University Certified Review Board | |
| 2-5-1 Shkata-cho, Kita-ku, Okayama | |
+81-86-235-7133 |
|
| ouh-crrb@adm.okayama-u.ac.jp | |
| Approval | |
Oct. 29, 2020 |
None |